Global Glucose Tolerance Test Market

Glucose Tolerance Test Market Size, Share, Growth Analysis, By Product(Smart Sensor, Blood Glucose Testing Kit, Meters, Test Slips and Other), By Disease Indication(Reactive Hypoglycemia, Diabetes Hypoglycemia, Gestational Diabetes, Insulin Resistance), By End User(Hospitals, Home, Diagnostic Clinic, and Others), By Region - Industry Forecast 2024-2031


Report ID: SQMIG35D2225 | Region: Global | Published Date: April, 2024
Pages: 213 | Tables: 94 | Figures: 71

Glucose Tolerance Test Market Competitive Landscape

The market is extremely fragmented, with a significant number of medium-, small-, and big-sized providers. Key multinational players that are attempting to innovate and broaden their market reach are what define the competitive landscape of the global glucose tolerance test market. Prominent players in this field include Abbott Laboratories, Roche Diagnostics, Dexcom Inc., Medtronic plc, and Ascensia Diabetes Care Holdings AG. These businesses make constant investments in R&D to bring cutting-edge glucose monitoring technologies to the market and expand their product lines, which increases competition and spurs market expansion.

Top Player’s Company Profiles

  • Johnson & Johnson Inc (US)
  • Bayer AG (Germany)
  • Panasonic (Japan)
  • Sanofi (France)
  • Penlan Healthcare Ltd. (UK)
  • Ascensia Diabetes Care Holdings AG (Switzerland)
  • E-Zlab Health Services (Canada)
  • Abbott Labs (US)
  • Laboratory Corporation of American Holdings (US)
  • Lifescan IP Holdings (US)
  • F.Hoffman-La Roche Ltd. (Switzerland)
  • Dexcom, Inc. (US)
  • Thermo Fisher Scientific Inc. (US)
  • Quest Diagnostics Incorporated (US)
  • Merck KGaA (Germany)

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Glucose Tolerance Test Market size was valued at USD 25603 million in 2022, USD 27110 million in 2023 and is projected to grow USD 41750 million by 2031, growing at a CAGR of 5.9% in the forecast period (2024-2031).

The market is extremely fragmented, with a significant number of medium-, small-, and big-sized providers. Key multinational players that are attempting to innovate and broaden their market reach are what define the competitive landscape of the glucose tolerance test market. Prominent players in this field include Abbott Laboratories, Roche Diagnostics, Dexcom Inc., Medtronic plc, and Ascensia Diabetes Care Holdings AG. These businesses make constant investments in R&D to bring cutting-edge glucose monitoring technologies to the market and expand their product lines, which increases competition and spurs market expansion. 'Johnson & Johnson Inc (US)', 'Bayer AG (Germany)', 'Panasonic (Japan)', 'Sanofi (France)', 'Penlan Healthcare Ltd. (UK)', 'Ascensia Diabetes Care Holdings AG (Switzerland)', 'E-Zlab Health Services (Canada)', 'Abbott Labs (US)', 'Laboratory Corporation of American Holdings (US)', 'Lifescan IP Holdings (US)', 'F.Hoffman-La Roche Ltd. (Switzerland)', 'Dexcom, Inc. (US)', 'Thermo Fisher Scientific Inc. (US)', 'Quest Diagnostics Incorporated (US)', 'Merck KGaA (Germany)'

The rising incidence of diabetes worldwide is a major factor behind the expansion of the market for glucose tolerance tests. The rise in diabetes incidence can be attributed to changes in lifestyle, such as sedentary behaviour and poor food, which raises the need for efficient diagnostic instruments like glucose tolerance testing. These tests are becoming more and more popular due to their critical role in the early diagnosis and treatment of diabetes.

Advancements in Diagnostic Technologies: Recent years have witnessed notable trends and developments in the glucose tolerance test (GTT) industry, which can be attributed to shifts in healthcare policies, improvements in diagnostic tools, and changing patient demands. One noteworthy trend is the rise in the prevalence of diabetes and prediabetes, which is being caused by ageing populations, bad diets, and sedentary lifestyles. The need for precise and trustworthy diagnostic tools, like the GTT, to identify those at risk and enable early intervention and management of the condition is increasing as the incidence of diabetes rises. The GTT market is expanding because of this trend, as healthcare professionals try to keep up with the rising demand for diabetes diagnosis and screening.

The North American region dominates the market since it holds the biggest market share in the industry. The rising cost of healthcare, the rise in diabetes cases, and the acceleration of technological advancements are the causes of this. The European area holds the second-largest market share in the market. The Eastern European and Western European regions are further divisions of this region. Western European nations include France, Germany, Spain, Italy, and the United Kingdom. The ageing population, improved research and development, and healthcare infrastructure all contribute to the market's expansion. The utilization of glucose tolerance tests is being propelled by advancements in healthcare infrastructure and heightened consciousness regarding the need for prompt diagnosis and management of diabetes.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Glucose Tolerance Test Market

Report ID: SQMIG35D2225

$5,300
BUY NOW GET FREE SAMPLE